Fused heterocyclic compounds useful as kinase modulators

Details for Australian Patent Application No. 2006295439 (hide)

Owner Bristol-Myers Squibb Company

Inventors Mussari, Christopher P.; Lin, James; Chen, Zhong; Tortolani, David R.; Huynh, Tram N.; Liu, Chunjian; Tokarski, John S.; Vaccaro, Wayne; Wrobleski, Stephen T.; Dodd, Dharmpal S.

Agent A J Park

Pub. Number AU-B-2006295439

PCT Pub. Number WO2007/038314

Priority 11/524,996 21.09.06 US; 60/719,519 22.09.05 US

Filing date 22 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 13 September 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/437

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/038314 Priority application(s): WO2007/038314

13 September 2012 Application Accepted

  Published as AU-B-2006295439

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006295440-Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

2006295430-Electrode array